Open for responses
FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Notice type
Special Notice
Solicitation #
FDABAA-27-00123
NAICS
541714
PSC
AJ11
Set-aside
No Set aside used
Posted
November 16, 2026
Response due
January 22, 2027
Description
Amendment 001 - 10/30/26 - Updated the proposal due date from 2/1/27 at 5:00 pm to 1/22/27 at 5:00 pm.
Updated the Special Notice Archive date from 15 days after response date to 09/30/27.
Amendment 002 - 11/16/26:
Summary of changes BAA Notice (FDABAA-27-00123) - Amendment 002:
Page 2 – Added updated information on BAA Day.
BAA Day: FY27 FDA BAA Day will provide an opportunity to learn more about the application process and the FDA’s priorities for regulatory science research. Fiscal Year (FY) 2027 FDA Broad Agency Announcement Day - 12/08/2026 | FDA
Page 7 – Added updated information on BAA Day.
BAA Day for FY2027 will be hosted on December 8, 2026 from 1:00 PM - 4:00 PM Eastern Standard Time, as a virtual only event and will provide an opportunity to learn more about the application process and FDA’s priorities for regulatory research (Fiscal Year (FY) 2027 FDA Broad Agency Announcement Day - 12/08/2026 | FDA).
Page 14 – Added new research interest to Section - 2. Enhancing Nonclinical Development
16. Compare multiple human tooth enamel evaluation techniques (including but not limited to surface and cross-sectional microhardness) to explore critical parameters and refine demineralization-remineralization NAMs for the testing of over-the-counter anticaries dentifrice drug products.
Page 52 – Updated Section - 22 - Tobacco and Nicotine with Super Intelligence (SI)
(SI) [18]
[18] Per Executive Order 14434 , federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI)
Page 53-56 - Section - 22 - Tobacco and Nicotine
Updated numerical bullet points. The content did not change.
Added page numbers to the footer of the BAA Notice.
Notice:
In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement.
FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation.
Source: SAM.gov, as posted. Verify the current solicitation before responding.
Pursue this opportunity with Mindy
See who holds it now, who else is bidding, and draft your response — grounded in real government data, not generic AI.
View the original notice on SAM.gov ↗Open opportunities in NAICS 541714
Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
DEPT OF DEFENSE · Special Notice
FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
HEALTH AND HUMAN SERVICES, DEPARTMENT OF · Special Notice · due January 22, 2027
Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
HEALTH AND HUMAN SERVICES, DEPARTMENT OF · Solicitation · due November 30, 2026
Illumina NovaSeq 6000 S4 Reagent Kits
DEPT OF DEFENSE · Special Notice · due November 20, 2026
Presolicitation Notice to Sole Source for Experimental Pathology Laboratories, Inc. (EPL)
ENVIRONMENTAL PROTECTION AGENCY · Special Notice · due November 30, 2026
Laguna Industry Day
DEPT OF DEFENSE · Special Notice · due December 2, 2026